A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

@article{Wade2003APC,
  title={A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms},
  author={D. Wade and P. Robson and H. House and P. Makela and J. Aram},
  journal={Clinical Rehabilitation},
  year={2003},
  volume={17},
  pages={21 - 29}
}
Objectives: To determine whether plant-derived cannabis medicinal extracts (CME) can alleviate neurogenic symptoms unresponsive to standard treatment, and to quantify adverse effects. Design: A consecutive series of double-blind, randomized, placebo-controlled single-patient cross-over trials with two-week treatment periods. Setting: Patients attended as outpatients, but took the CME at home. Subjects: Twenty-four patients with multiple sclerosis (18), spinal cord injury (4), brachial plexus… Expand
360 Citations

Paper Mentions

Interventional Clinical Trial
This is a 10-week, randomised, double blind, placebo-controlled, crossover trial to investigate the effect of Cannabis Based Medicine Extract (Sativex) on patterns of brain… Expand
ConditionsMultiple Sclerosis
InterventionDrug
The therapeutic value of cannabinoids in MS: real or imaginary?
  • 12
  • PDF
Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
  • 74
  • Highly Influenced
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 26 REFERENCES
Treatment of human spasticity with delta 9-tetrahydrocannabinol.
  • 73
...
1
2
3
...